D-0824-2020 Class II Terminated

Recalled by Pharmaceutical Associates Inc — Greenville, SC

FDA drug recall D-0824-2020 was initiated by Pharmaceutical Associates Inc on Jan 14, 2020 and is designated Class II. Reason for recall: Subpotent: Out of specification for assay at the 12-month time point. The recall status is terminated (terminated Jun 3, 2021). Affected quantity: 6288 16 oz bottles.

Recall details

Product Type
Drugs
Report Date
Feb 5, 2020
Initiation Date
Jan 14, 2020
Termination Date
Jun 3, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6288 16 oz bottles

Product description

Nystatin Oral Suspension, USP 100,000 units per mL Cherry/Peppermint Flavor, 16 fl oz (473 mL) Rx Only, pai, Pharmaceutical Associates, Inc. Greenville, SC 29605. NDC 0121-0810-16

Reason for recall

Subpotent: Out of specification for assay at the 12-month time point.

Distribution pattern

Distributed Nationwide in the US

Code information

Lots: BB70, BB71 Exp. May 2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0824-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0824-2020. Report a data issue: hello@regdatalab.com.